dimethylformamide has been researched along with pulmicort in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hipkiss, D; Kubavat, HA; Price, R; Ruecroft, G; Shur, J | 1 |
| Ikkala, O; Junnila, S; Kauppinen, E; Rahikkala, A; Raula, J; Ruokolainen, J; Vartiainen, V | 1 |
2 other study(ies) available for dimethylformamide and pulmicort
| Article | Year |
|---|---|
Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
Topics: Acetone; Administration, Inhalation; Aerosols; Bronchodilator Agents; Budesonide; Chemistry, Pharmaceutical; Colloids; Crystallization; Dimethylformamide; Drug Carriers; Drug Compounding; Dry Powder Inhalers; Elastic Modulus; Lactose; Microscopy, Atomic Force; Nanotechnology; Particle Size; Powders; Solvents; Surface Properties; Technology, Pharmaceutical; Water | 2012 |
Polypeptide-based aerosol nanoparticles: self-assembly and control of conformation by solvent and thermal annealing.
Topics: 1-Propanol; Aerosols; Benzenesulfonates; Budesonide; Chloroform; Dimethylformamide; Drug Carriers; Ketoprofen; Kinetics; Molecular Conformation; Nanoparticles; Particle Size; Peptides; Polylysine; Protein Structure, Secondary; Solubility; Solvents; Surface-Active Agents | 2014 |